Example 2. Reported Side Effects at 12-Months for Active and Placebo Groups in TOMHS
 

Condition

Active Group

Placebo Group

P-Value

Drowsiness

78 (12.3%)

24 (10.7%)

0.551

Tiredness

112 (17.7%)

55 (24.4%)

0.031

Faintness

50 (7.9%)

18 (8.0%)

1.000

Itchy Skin

79 (12.5%)

24 (10.7%)

0.551

Skin Rash

55 (8.7%)

18 (8.0%)

0.889

Headaches

136 (21.5%)

52 (23.1%)

0.639

Ringing in Ears

86 (13.6%)

31 (13.8%)

0.910

Stuffy Nose

168 (26.5%)

64 (28.4%)

0.600

Dry Mouth

44 (6.9%)

17 (7.6%)

0.763

Cough

69 (10.9%)

28 (12.4%)

0.541

Fast Heart Rate

46 (7.3%)

16 (7.1%)

1.000

Chest Pain

43 (6.8%)

23 (10.2%)

0.109

Joint Pain

187 (29.5%)

69 (30.7%)

0.735

Swelling Feet

38 (6.0%)

16 (7.1%)

0.527

Muscle Cramps

84 (13.2%)

38 (16.9%)

0.183

Numbness

66 (10.4%)

27 (12.0%)

0.533

Trouble Sleeping

65 (10.3%)

23 (10.2%)

1.000

Waking up Early

107 (16.9%)

40 (17.8%)

0.758

Mood Changes

43 (6.8%)

22 (9.8%)

0.145

Depressed

76 (12.0%)

26 (11.6%)

0.905

Number of Participants

634

225

 

Notes:   Values in table are number with condition (percent). P-values based on Fishers exact test

pn=example2 rundate=31AUG2018